These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
121 related articles for article (PubMed ID: 130137)
41. Immunologic abnormality in NZB/NZW F1 mice. Thymus-independent occurrence of B cell abnormality and requirement for T cells in the development of autoimmune disease, as evidenced by an analysis of the athymic nude individuals. Mihara M; Ohsugi Y; Saito K; Miyai T; Togashi M; Ono S; Murakami S; Dobashi K; Hirayama F; Hamaoka T J Immunol; 1988 Jul; 141(1):85-90. PubMed ID: 3259971 [TBL] [Abstract][Full Text] [Related]
43. Effects of pulse cyclophosphamide on NZB/W disease. Chia D; Levy L; Barnett EV; Carnes WH Immunology; 1981 May; 43(1):57-65. PubMed ID: 6454649 [TBL] [Abstract][Full Text] [Related]
44. Interleukin-6 exacerbates glomerulonephritis in (NZB x NZW)F1 mice. Ryffel B; Car BD; Gunn H; Roman D; Hiestand P; Mihatsch MJ Am J Pathol; 1994 May; 144(5):927-37. PubMed ID: 8178944 [TBL] [Abstract][Full Text] [Related]
45. The contribution of NZW genes to lupus-like disease in (NZB x NZW)F1 mice. Kotzin BL; Palmer E J Exp Med; 1987 May; 165(5):1237-51. PubMed ID: 3494806 [TBL] [Abstract][Full Text] [Related]
46. A comparison of anti-DNA antibodies from serum and kidney eluates of NZB x NZW F1 mice. Dang H; Harbeck RJ J Clin Lab Immunol; 1982 Nov; 9(2):139-45. PubMed ID: 6984079 [TBL] [Abstract][Full Text] [Related]
47. Resistance to therapy in mature Palmerston North mice treated with cyclophosphamide or hydrocortisone sodium succinate. Walker SE; Schnitzer B Arthritis Rheum; 1980 May; 23(5):539-44. PubMed ID: 6966498 [TBL] [Abstract][Full Text] [Related]
48. In vivo and in vitro production of anti-histone antibodies in NZB/NZW mice. Gioud M; Kotzin BL; Rubin RL; Joslin FG; Tan EM J Immunol; 1983 Jul; 131(1):269-74. PubMed ID: 6863918 [TBL] [Abstract][Full Text] [Related]
49. Influence of dietary restriction on immunologic function and renal disease in (NZB x NZW) F1 mice. Fernandes G; Friend P; Yunis EJ; Good RA Proc Natl Acad Sci U S A; 1978 Mar; 75(3):1500-4. PubMed ID: 306627 [TBL] [Abstract][Full Text] [Related]
50. Marked reduction of DNA antibody production and glomerulopathy in thymulin (FTS-Zn) or cyclosporin A treated (NZB X NZW) F1 mice. Israel-Biet D; Noel LH; Bach MA; Dardenne M; Bach JF Clin Exp Immunol; 1983 Nov; 54(2):359-65. PubMed ID: 6360436 [TBL] [Abstract][Full Text] [Related]
51. Ability of the xid gene to prevent autoimmunity in (NZB X NZW)F1 mice during the course of their natural history, after polyclonal stimulation, or following immunization with DNA. Steinberg BJ; Smathers PA; Frederiksen K; Steinberg AD J Clin Invest; 1982 Sep; 70(3):587-97. PubMed ID: 6980900 [TBL] [Abstract][Full Text] [Related]
52. Genetic contributions to lupus-like disease in NZB/NZW mice. Kotzin BL; Palmer E Am J Med; 1988 Dec; 85(6A):29-31. PubMed ID: 3264457 [TBL] [Abstract][Full Text] [Related]
53. Treatment with antibody reactive with the nephritogenic idiotype, IdLNF1, suppresses its production and leads to prolonged survival of (NZB x SWR)F1 mice. Uner AH; Knupp CJ; Tatum AH; Gavalchin J J Autoimmun; 1994 Feb; 7(1):27-44. PubMed ID: 8198700 [TBL] [Abstract][Full Text] [Related]
54. Hidden anti-nuclear antibodies in sero-negative systemic lupus erythematosus patients and in NZB and (NZB x NZW) F 1 mice. Blomjous FJ; Feltkamp-Vroom TM Eur J Immunol; 1971 Nov; 1(5):396-8. PubMed ID: 4110262 [No Abstract] [Full Text] [Related]
55. The course of autoimmune disease in parous NZB/NZW mice. Castor R; Walker SE J Comp Pathol; 1977 Jan; 87(1):35-42. PubMed ID: 300081 [No Abstract] [Full Text] [Related]
56. A novel susceptibility locus on chromosome 2 in the (New Zealand Black x New Zealand White)F1 hybrid mouse model of systemic lupus erythematosus. Rahman ZS; Tin SK; Buenaventura PN; Ho CH; Yap EP; Yong RY; Koh DR J Immunol; 2002 Mar; 168(6):3042-9. PubMed ID: 11884477 [TBL] [Abstract][Full Text] [Related]